Health/Medical Research

Grants will be awarded in support of the advancement of neuroimaging and CSF biomarkers that can do one or more of the following:

Two grants will be awarded in support of exceptionally novel and creative projects with great potential to produce significant advances in our understanding of the management of bladder cancer. Proposed research may be basic, translational, clinical, or epidemiological and must have direct applicability and relevance to bladder cancer.

Grants will be awarded in support of a variety of arthritis-related research grants for research scientists and researchers working on arthritis and related autoimmune diseases. Clinical and basic studies will be considered; clinical studies should have a translational component that helps reveal the underlying mechanisms or response to therapy.

Grants will be awarded in support of early career investigators pursuing clinical and/or basic research in men’s or women’s sexual health.

A single grant will be awarded in support of a project focused on the broad area of injectable orthobiologics for the treatment of knee osteoarthritis.

Applications are invited for basic, translational, or clinical research projects in rhinology conducted by any member of the American Rhinologic Society who has completed his/her residency and has not previously received significant outside funding. Applicants must have an established researcher as a mentor who will provide a letter of support stating the extent of involvement in the project and a summary of his/her research experience.

Applications are invited for one-year proposals that enable all the capabilities of a new cancer researcher or new cancer approach by an established cancer researcher to be established. The foundation anticipates that this early-stage funding may lead to subsequent and expanded support from a government agency or other source. In addition, the relevance of the project to cancer detection, treatment, or cure should be clearly identified.

Grants will be awarded to assist anesthesiologists in developing the skills and preliminary data needed to become independent investigators in the field of anesthesia patient safety. APSF/FAER is interested in funding patient safety research directly relevant to the perioperative care of patients, as well as chronic pain and critical care medicine.

Applications are invited for postdoctoral support for up to three years from young scientists early in their careers. Research scope includes manifestations of all types of NF1, NF2, schwannomatosis, including neurofibromas, schwannomas, malignant peripheral nerve sheath tumors, and other brain and nervous system tumors; bone abnormalities; cardiovascular abnormalities; learning disorders; and pain.

Grants will be awarded to research projects that are likely to lead to clinical treatment trials within five years, including the discovery and/or testing of candidate treatment compounds in cell-based or animal models of Hutchinson-Gilford Progeria Syndrome; the development of gene-, biomolecule-, drug-, and cell-based therapies to treat progeria; and/or assessments of the natural history of disease that may be important to developing outcome measures in treat